These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8623727)

  • 21. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS
    AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug approval.
    AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV therapeutics, continued: another HIV protease inhibitor approved.
    Laurence J
    AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral approved for use in infants.
    Am Fam Physician; 2001 Jun; 63(12):2469. PubMed ID: 11430459
    [No Abstract]   [Full Text] [Related]  

  • 25. Kaletra (ABT-378/r) approved.
    James JS
    AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new class of anti-HIV drugs debuts.
    Am J Nurs; 1996 Jul; 96(7):59-63. PubMed ID: 8659572
    [No Abstract]   [Full Text] [Related]  

  • 28. Indinavir: lightening the load.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Aug; 2(8):6-11. PubMed ID: 11363759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric treatments.
    AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 31. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tipranavir gets approved.
    AIDS Patient Care STDS; 2005 Sep; 19(9):615-6. PubMed ID: 16245408
    [No Abstract]   [Full Text] [Related]  

  • 33. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 34. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 35. [New drugs, new obstacles in the fight against HIV].
    Fonseca MS
    Sidahora; 1996; ():13-4. PubMed ID: 11364289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indinavir marketed under accelerated-approval program.
    Am J Health Syst Pharm; 1996 May; 53(9):982. PubMed ID: 8744452
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA notifications. Atazanavir capsule label is updated for pediatric patients.
    AIDS Alert; 2008 May; 23(5):59-60. PubMed ID: 18637262
    [No Abstract]   [Full Text] [Related]  

  • 40. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.